---
$id: https://graph.org.ai/products/commodity/51433913
$type: Product
source: UNSPSC
code: "51433913"
title: "Clevidipine"
class: "51433900"
classTitle: "Antihypertensive pyridines"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clevidipine

**UNSPSC Code**: 51433913
**Class**: [Antihypertensive pyridines](Antihypertensive pyridines.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a calcium channel blocker with the molecular formula C21H23Cl2NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19O2GP3B7Q, chemically known as 3,5-pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl (1-oxobutoxy)methyl ester but generally known as clevidipine, which bears US NIH Compound Identifier 153994. European Medicines Agency schedules Clevidipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06655MIG. The term CLEVIDIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 11997, List 37). World Health Organization schedules clevidipine in its Anatomical Therapeutic Chemical (ATC) Classification. CLEVIDIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clevidipine under HS 29333999 and SITC 51574. As of Q4 2014, CLEVIDIPINE remains the US FDA Preferred Term for this commodity. Clevidipine bears US NLM identifiers UMLS ID C0766108 and NCI Concept Code C72727. SMILES: Clc1c(C2C(=C(NC(=C2C(=O)OC)C)C)C(=O)OCOC(=O)CCC)cccc1Cl.

